Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Regulatory News (MXCT)

  • There is currently no data for MXCT

MaxCyte

23 Jun 2025 18:00

RNS Number : 0278O
FTSE Russell
23 June 2025
 

 

 

Maxcyte Inc (UK): Constituent DeletionChanges in FTSE UK Index Series

23 June 2025

Subject to the expected cancellation of trading on AIM for Maxcyte Inc (UK, constituent), please see details of affected indexes and effective dates below:

 

 

Index

Effective FromStart of Trading

FTSE AIM 100 Index

26 June 2025

FTSE AIM All-Share Index

26 June 2025

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+61 (0) 2 7228 5659

Hong Kong

+852 2164 3333

Japan

+81 3 6441 1430

London

+44 (0) 20 7866 1810

New York

+1877 503 6437

Alternatively, please visit our website at lseg.com/ftse-russell

 

Terms of Use | Copyright © 2025 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FTSEALKDAEESEFA
Date   Source Headline
26th Jun 20257:00 amRNSCancellation - Maxcyte Inc
25th Jun 20257:00 amRNSLast Day of Dealings on AIM
23rd Jun 20256:00 pmRNSMaxCyte
19th Jun 20257:00 amRNSResult of Annual General Meeting
12th Jun 20257:00 amRNSHolding(s) in Company
11th Jun 20257:00 amRNS-RMaxCyte and Ori Biotech Announce Collaboration
6th Jun 20259:33 amRNSHolding(s) in Company
5th Jun 20252:16 pmRNSHolding(s) in Company
2nd Jun 20255:14 pmRNSTotal Voting Rights
2nd Jun 20254:17 pmRNSHolding(s) in Company
29th May 20257:06 amRNSHolding(s) in Company
23rd May 20254:52 pmRNSHolding(s) in Company
23rd May 20254:26 pmRNSHolding(s) in Company
23rd May 20257:00 amRNSHolding(s) in Company
19th May 20256:05 pmRNSHolding(s) in Company
16th May 20253:12 pmRNSHolding(s) in Company
9th May 20257:00 amRNSFiling of Form 10-Q
8th May 20257:00 amRNSFirst Quarter 2025 Financial Results
2nd May 20254:40 pmRNSTotal Voting Rights
28th Apr 20257:00 amRNSFiling of definitive proxy statement
22nd Apr 20252:43 pmRNSHolding(s) in Company
22nd Apr 20252:37 pmRNSHolding(s) in Company
15th Apr 20255:00 pmRNSHolding(s) in Company
15th Apr 20257:00 amRNSProposed cancellation of trading on AIM
14th Apr 20259:17 amRNSHolding(s) in Company
10th Apr 20257:00 amRNSMaxCyte to Report Q1 2025 Results on May 7, 2025
8th Apr 20253:35 pmRNSHolding(s) in Company
1st Apr 20255:57 pmRNSTotal Voting Rights
26th Mar 202510:14 amRNSCorrection: Vesting of RSUs and PDMR Dealing
26th Mar 20257:00 amRNSVesting of RSUs and PDMR Dealing
25th Mar 202510:30 amRNSHolding(s) in Company
25th Mar 202510:28 amRNSHolding(s) in Company
25th Mar 202510:26 amRNSHolding(s) in Company
25th Mar 202510:22 amRNSHolding(s) in Company
24th Mar 20259:06 amRNSGrant of Options, RSUs and PSUs and PDMR Dealing
19th Mar 20252:07 pmRNSHolding(s) in Company
12th Mar 20257:01 amRNSFiling of Form 10-K for FY ended December 31, 2024
12th Mar 20257:00 amRNSQ4 & FY 2024 Financial Results
4th Mar 20253:38 pmRNSTotal Voting Rights
19th Feb 20253:23 pmRNSHolding(s) in Company
14th Feb 20255:05 pmRNSHolding(s) in Company
13th Feb 20254:12 pmRNSHolding(s) in Company
13th Feb 20252:52 pmRNSHolding(s) in Company
12th Feb 20257:00 amRNSStrategic Platform License with TG Therapeutics
7th Feb 20257:00 amRNSNotice of Results
4th Feb 20257:00 amRNSTotal Voting Rights
31st Jan 20253:18 pmRNSExercise of options and PDMR dealing
30th Jan 20257:00 amRNSMaxCyte® Acquires SeQure Dx
29th Jan 20253:05 pmRNSHolding(s) in Company
22nd Jan 20252:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.